Javascript must be enabled to continue!
Protein expression of myostatin and follistatin in the myocardium of spontaneously hypertensive rats with heart failure
View through CrossRef
The aim of this study was to evaluate myocardial myostatin and follistatin protein expression in spontaneously hypertensive rats (SHR) with heart failure (HF).Methods18‐month‐old SHR's were evaluated to identify clinical features of HF: tachypnea/labored respiration and weight loss. After HF was detected, rats were subjected to transthoracic echocardiogram and euthanized. During euthanasia, we evaluated pathological evidence of HF such as pulmonary congestion and right ventricular hypertrophy. Wistar‐Kyoto (WKY) rats were used as controls. Myostatin and follistatin protein expression was assessed by Western blotting.ResultsAll SHR's (n=8) presented tachypnea, lung congestion and right ventricular hypertrophy. No WKY rat (n=8) presented any feature of HF. Echocardiographic evaluation showed left chambers dilation (left atrial diameter: WKY 5.73±0.59; SHR 7.28±1.17 mm; p=0.004; left ventricular diastolic diameter/body weight ratio: WKY 19.6±3.1; SHR 27.7±4.7 mm/kg; p=0.001), and left ventricular systolic (fractional shortening: WKY 54.6±6.3; SHR 42.2±7.1 %; p=0.003) and diastolic dysfunction in SHR. Myostatin (WKY 1.00±0.16; SHR 0.77±0.23 arbitrary units; p=0.035) and follistatin (WKY 1.00±0.35; SHR 0.49±0.18 arbitrary units; p=0.002) protein expression was lower in SHR.ConclusionMyostatin and follistatin protein expression is reduced in myocardium of SHR with heart failure.
Title: Protein expression of myostatin and follistatin in the myocardium of spontaneously hypertensive rats with heart failure
Description:
The aim of this study was to evaluate myocardial myostatin and follistatin protein expression in spontaneously hypertensive rats (SHR) with heart failure (HF).
Methods18‐month‐old SHR's were evaluated to identify clinical features of HF: tachypnea/labored respiration and weight loss.
After HF was detected, rats were subjected to transthoracic echocardiogram and euthanized.
During euthanasia, we evaluated pathological evidence of HF such as pulmonary congestion and right ventricular hypertrophy.
Wistar‐Kyoto (WKY) rats were used as controls.
Myostatin and follistatin protein expression was assessed by Western blotting.
ResultsAll SHR's (n=8) presented tachypnea, lung congestion and right ventricular hypertrophy.
No WKY rat (n=8) presented any feature of HF.
Echocardiographic evaluation showed left chambers dilation (left atrial diameter: WKY 5.
73±0.
59; SHR 7.
28±1.
17 mm; p=0.
004; left ventricular diastolic diameter/body weight ratio: WKY 19.
6±3.
1; SHR 27.
7±4.
7 mm/kg; p=0.
001), and left ventricular systolic (fractional shortening: WKY 54.
6±6.
3; SHR 42.
2±7.
1 %; p=0.
003) and diastolic dysfunction in SHR.
Myostatin (WKY 1.
00±0.
16; SHR 0.
77±0.
23 arbitrary units; p=0.
035) and follistatin (WKY 1.
00±0.
35; SHR 0.
49±0.
18 arbitrary units; p=0.
002) protein expression was lower in SHR.
ConclusionMyostatin and follistatin protein expression is reduced in myocardium of SHR with heart failure.
Related Results
Estrogen Effects on Skeletal Muscle Insulin-Like Growth Factor–1 and Myostatin in Ovariectomized Rats
Estrogen Effects on Skeletal Muscle Insulin-Like Growth Factor–1 and Myostatin in Ovariectomized Rats
Previous work showed that estrogen replacement attenuates muscle growth in immature rats. The present study examined muscle insulin-like growth factor–1 (IGF-1) and myostatin expre...
Circulating follistatin concentrations in adolescent PCOS: Divergent effects of randomized treatments
Circulating follistatin concentrations in adolescent PCOS: Divergent effects of randomized treatments
PurposeFollistatin is a glycoprotein that represses members of the transforming growth factor-β superfamily including activin. Higher follistatin levels have been associated with a...
e0157 RNA interference targeting ACE and AT1R gene reduced blood pressure and improved myocardial remodelling in SHR
e0157 RNA interference targeting ACE and AT1R gene reduced blood pressure and improved myocardial remodelling in SHR
Introduction
Angiotensin-converting enzyme (ACE) and angiotensin II (Ang II) Type 1 receptor (ATlR) have been shown to play an important role in the pathogenesis ...
HYPERTENSIVE CRISES: HYPERTENSIVE EMERGENCY AND CRISIS MANAGEMENT DURING ANESTHESIA
HYPERTENSIVE CRISES: HYPERTENSIVE EMERGENCY AND CRISIS MANAGEMENT DURING ANESTHESIA
Introduction: hypertensive crisis is characterized by an acute and massive increase in blood pressure. Hypertensive crises encompass several clinical situations with different seve...
ASSA13-03-33 Effects of b3-Adrenergic Receptor Antagonist on SOCS3 Expression and Cell Apoptosis in Heart Failure Model Rats
ASSA13-03-33 Effects of b3-Adrenergic Receptor Antagonist on SOCS3 Expression and Cell Apoptosis in Heart Failure Model Rats
Objective
To observe the influence of β3-AR antagonist on expression of Suppressor of cytokine signalling 3 (SOCS3), receptor serine/threonine kinases (Akt), pAkt...
Myostatin negatively regulates satellite cell activation and self-renewal
Myostatin negatively regulates satellite cell activation and self-renewal
Satellite cells are quiescent muscle stem cells that promote postnatal muscle growth and repair. Here we show that myostatin, a TGF-β member, signals satellite cell quiescence and ...
Metabolic syndrome in hypertensive and non‐hypertensive subjects
Metabolic syndrome in hypertensive and non‐hypertensive subjects
AbstractBackground and aimsHypertension is a major risk factor of cardiovascular diseases (CVDs), which attributes to one‐third of all deaths worldwide. It is also considered as a ...
Myostatin: Expanding horizons
Myostatin: Expanding horizons
AbstractMyostatin is a secreted growth and differentiation factor that belongs to the TGF‐β superfamily. Myostatin is predominantly synthesized and expressed in skeletal muscle and...

